Feasibility of using recombinant factor VIIa in continuous infusion. [electronic resource]
Producer: 19960905Description: 432-6 p. digitalISSN:- 0340-6245
- Drug Stability
- Drug Therapy, Combination
- Factor VIIa -- adverse effects
- Feasibility Studies
- Half-Life
- Hemophilia A -- drug therapy
- Hemostatics -- adverse effects
- Heparin -- therapeutic use
- Humans
- Infusion Pumps
- Injections, Intravenous
- Recombinant Proteins -- adverse effects
- Sterilization
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.